Replimune retweeted
The MRF Breakthrough Consortium (MRFBC) annual in-person meeting is officially underway at #ASCO2025!
This important gathering brings together leaders in melanoma research and clinicians to exchange insights, strengthen collaboration and drive progress in the field.
We’re looking forward to an evening of innovation and momentum at @ASCO.
Thank you to our sponsors @Immunocore, @Replimune, @Iovance and @pfizer for your support of this meeting!
#MRFBC #MelanomaResearch #ASCO25
Replimune retweeted
In just a few hours, we will join Dr. Gino from @uscnorris and patient Advocate, Donna Soskin for our Ask the Expert series as they discuss the mechanisms of how oncolytic viruses work against cancer, how these viruses are designed to minimize risk of infection, the patient perspective on oncolytic virus therapies and more! Special thanks to @Replimune for sponsoring this event. There's still time to join, so register today - buff.ly/48oLAjZ
Replimune retweeted
Replying to @AstleySparke
@AstleySparke, CEO of @Replimune, says the clinical-stage #biotechnology company is on the verge of successfully developing a new generation of #immunotherapy cancer treatments.
pharmavoice.com/news/replimu…
Replimune retweeted
🧬Next Wednesday, Jan 26th @InfoGetica in collaboration with @Replimune organizes the webinar "Understanding How Oncolytic Viruses Tackle the Cold Tumor Space". Save the date and check all the information in getica.org. Join us, free registration!!
#immunotherapy







